Korean J Gastroenterol.  2025 Jul;85(3):280-285. 10.4166/kjg.2025.019.

Risk of Pancreatic Cancer in Inflammatory Pancreatic Diseases

• Löhr JM
• Vujasinovic M
• Maisonneuve P

• KMID: 2570611
• DOI: http://doi.org/10.4166/kjg.2025.019

Abstract

All known inflammatory diseases of the pancreas, i.e., acute, chronic, hereditary, and autoimmune pancreatitis, carry a higher risk of developing pancreatic cancer. The risk is highest in hereditary and chronic pancreatitis and lowest in acute and autoimmune pancreatitis. Although established risk factors such as smoking have been known for decades, obesity, diabetes mellitus, and pancreatic exocrine insufficiency have emerged. In addition, the microbiome/use of antibiotics and microplastic are novel risk factors for the development of pancreatic cancer that have not been explored.

Keyword

Acute pancreatitis; Chronic pancreatitis; Hereditary pancreatitis; Autoimmune pancreatitis; Pancreatic cancer

Reference

1. Lim NR, Chung WC. 2023; Helicobacter pylori-associated chronic atrophic gastritis and progression of gastric carcinogenesis. Korean J Gastroenterol. 82:171–179. DOI: 10.4166/kjg.2023.097. PMID: 37876256.

2. Axelrad JE, Rubin DT. 2024; The Management of colorectal neoplasia in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 22:1181–1185. DOI: 10.1016/j.cgh.2024.01.030. PMID: 38432648. PMCID: PMC11128355.

3. Souza M, Lima LCV, Al-Sharif L, Huang DQ. Incidence of hepatobiliary malignancies in primary sclerosing cholangitis: Systematic review and meta-analysis. Clin Gastroenterol Hepatol 2024 Dec 19. doi: 10.1016/j.cgh.2024.09.037. 10.1016/j.cgh.2024.09.037

4. Mak LY, Liu K, Chirapongsathorn S, et al. 2024; Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions. Nat Rev Gastroenterol Hepatol. 21:834–851. DOI: 10.1038/s41575-024-00967-4. PMID: 39147893.

5. Thierens N, Verdonk RC, Löhr JM, van Santvoort HC, Bouwense SA, van Hooft JE. 2025; Chronic pancreatitis. Lancet. 404:2605–2618. DOI: 10.1016/S0140-6736(24)02187-1. PMID: 39647500.

6. Michl P, Löhr M, Neoptolemos JP, et al. 2021; UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better. United European Gastroenterol J. 9:860–871. DOI: 10.1002/ueg2.12123. PMID: 34431604. PMCID: PMC8435257.

7. Cho J, Petrov MS. 2020; Pancreatitis, pancreatic cancer, and their metabolic sequelae: Projected burden to 2050. Clin Transl Gastroenterol. 11:e00251. DOI: 10.14309/ctg.0000000000000251. PMID: 33259158. PMCID: PMC7594914.

8. Löhr JM, Öhlund D, Söreskog E, et al. 2024; Can our experience with surveillance for inherited pancreatic cancer help to identify early pancreatic cancer in the general population? Fam Cancer. 23:399–403. DOI: 10.1007/s10689-024-00363-6. PMID: 38441833. PMCID: PMC11255073.

9. Löhr JM, Vujasinovic M, Kartalis N, Osten P. 2024; Pancreatic incidentaloma: incidental findings from history towards the era of liquid biopsy. eGastroenterology. 2:e100082. DOI: 10.1136/egastro-2024-100082. PMID: 39944362. PMCID: PMC11770461.

10. Munigala S, Almaskeen S, Subramaniam DS, et al. 2023; Acute pancreatitis recurrences augment long-term pancreatic cancer risk. Am J Gastroenterol. 118:727–737. DOI: 10.14309/ajg.0000000000002081. PMID: 36473072. PMCID: PMC10045975.

11. Jeong SH, Hurh K, Park EC, Leigh JH, Kim SH, Jang SI. 2024; Risk of pancreatic cancer after acute pancreatitis: A retrospective analysis of the Korean national sample cohort. J Korean Med Sci. 39:e21. DOI: 10.3346/jkms.2024.39.e21. PMID: 38288535. PMCID: PMC10825454.

12. Zhang X, An R, Tian H, Zhao J. 2019; Increased risk of pancreatic cancer after acute pancreatitis: A meta-analysis of prospective cohort studies. Clin Res Hepatol Gastroenterol. 43:e39–e41. DOI: 10.1016/j.clinre.2018.09.008. PMID: 30392817.

13. de Rijk F, Sissingh NJ, Boel TT, et al. 2024; Development of pancreatic diseases during long-term follow-up after acute pancreatitis: a post-hoc analysis of a prospective multicenter cohort. J Gastroenterol Hepatol. 39:674–684. DOI: 10.1111/jgh.16453. PMID: 38191176.

14. Luong TQ, Chen Q, Tran TM, et al. 2022; Clinical and imaging predictors of pancreatic cancer in patients hospitalized for acute pancreatitis. Gastro Hep Adv. 1:1027–1036. DOI: 10.1016/j.gastha.2022.07.009. PMID: 39131243. PMCID: PMC11308526.

15. Andersson R, Ansari D. 2024; Acute pancreatitis - one key to early detection of pancreatic cancer? Scand J Gastroenterol. 59:352–353. DOI: 10.1080/00365521.2023.2281251. PMID: 37947300.

16. Lowenfels AB, Maisonneuve P, Cavallini G, et al. 1993; Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med. 328:1433–1437. DOI: 10.1056/NEJM199305203282001. PMID: 8479461.

17. Kim HS, Gweon TG, Park SH, Kim TH, Kim CW, Chang JH. 2023; Incidence and risk of pancreatic cancer in patients with chronic pancreatitis: defining the optimal subgroup for surveillance. Sci Rep. 13:106. DOI: 10.1038/s41598-022-26411-8. PMID: 36596818. PMCID: PMC9810784.

18. Haas SL, Ye W, Löhr JM. 2012; Alcohol consumption and digestive tract cancer. Curr Opin Clin Nutr Metab Care. 15:457–467. DOI: 10.1097/MCO.0b013e3283566699. PMID: 22797570.

19. Schneider A, Löhr JM, Singer MV. 2007; The M-ANNHEIM classification of chronic pancreatitis: introduction of a unifying classification system based on a review of previous classifications of the disease. J Gastroenterol. 42:101–119. DOI: 10.1007/s00535-006-1945-4. PMID: 17351799.

20. Olesen SS, Nøjgaard C, Poulsen JL, et al. 2019; Chronic pancreatitis is characterized by distinct complication clusters that associate with etiological risk factors. Am J Gastroenterol. 114:656–664. DOI: 10.14309/ajg.0000000000000147. PMID: 30741740.

21. Vujasinovic M, Dugic A, Maisonneuve P, et al. 2020; Risk of developing pancreatic cancer in patients with chronic pancreatitis. J Clin Med. 9:3720. DOI: 10.3390/jcm9113720. PMID: 33228173. PMCID: PMC7699479.

22. Kirkegård J, Mortensen FV, Cronin-Fenton D. 2017; Chronic pancreatitis and pancreatic cancer risk: A systematic review and meta-analysis. Am J Gastroenterol. 112:1366–1372. DOI: 10.1038/ajg.2017.218. PMID: 28762376.

23. Vujasinovic M, Maisonneuve P, Löhr JM. 2025; Ensuring timely detection of neoplastic transformation by surveilling chronic pancreatitis. Best Pract Res Clin Gastroenterol. 74:101985. DOI: 10.1016/j.bpg.2025.101985. PMID: 40210332.

24. Lowenfels AB, Maisonneuve P, Whitcomb DC, Lerch MM, DiMagno EP. 2001; Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA. 286:169–170. DOI: 10.1001/jama.286.2.169. PMID: 11448279.

25. Klein AP. 2021; Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol. 18:493–502. DOI: 10.1038/s41575-021-00457-x. PMID: 34002083. PMCID: PMC9265847.

26. Lanzillotta M, Vujasinovic M, Löhr JM, Della Torre E. 2025; Update on autoimmune pancreatitis and IgG4-related disease. United European Gastroenterol J. 13:107–115. DOI: 10.1002/ueg2.12738. PMID: 39707927. PMCID: PMC11866317.

27. Kanno A, Masamune A, Okazaki K, et al. 2015; Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011. Pancreas. 44:535–539. DOI: 10.1097/MPA.0000000000000325. PMID: 25815647.

28. Hart PA, Kamisawa T, Brugge WR, et al. 2013; Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut. 62:1771–1776. DOI: 10.1136/gutjnl-2012-303617. PMID: 23232048. PMCID: PMC3862979.

29. Kountouras J, Zavos C, Gavalas E, Tzilves D. 2007; Challenge in the pathogenesis of autoimmune pancreatitis: potential role of helicobacter pylori infection via molecular mimicry. Gastroenterology. 133:368–369. DOI: 10.1053/j.gastro.2007.05.044. PMID: 17631165.

30. Frulloni L, Lunardi C, Simone R, et al. 2009; Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med. 361:2135–2142. DOI: 10.1056/NEJMoa0903068. PMID: 19940298.

31. Löhr JM, Faissner R, Koczan D, et al. 2010; Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory process. Am J Gastroenterol. 105:2060–2071. DOI: 10.1038/ajg.2010.141. PMID: 20407433. PMCID: PMC3099227.

32. Felix K, Hauck O, Schnölzer M, et al. 2016; Identification of novel serum autoantibodies for differential diagnosis of autoimmune pancreatitis and pancreatic ductal adenocarcinoma. Pancreas. 45:1309–1319. DOI: 10.1097/MPA.0000000000000647. PMID: 27623556.

33. Jesnowski R, Isaksson B, Möhrcke C, et al. 2010; Helicobacter pylori in autoimmune pancreatitis and pancreatic carcinoma. Pancreatology. 10:462–466. DOI: 10.1159/000264677. PMID: 20720447.

34. Schneider A, Hirth M, Münch M, et al. 2017; Risk of cancer in patients with autoimmune pancreatitis: A single-center experience from Germany. Digestion. 95:172–180. DOI: 10.1159/000455963. PMID: 28226313.

35. Yoon SB, Jeon TY, Moon SH, et al. 2023; Differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma using CT characteristics: a systematic review and meta-analysis. Eur Radiol. 33:9010–9021. DOI: 10.1007/s00330-023-09959-5. PMID: 37466708.

36. Nikolic S, Ghorbani P, Pozzi Mucelli R, et al. 2022; Surgery in autoimmune pancreatitis. Dig Surg. 39:32–41. DOI: 10.1159/000521490. PMID: 34915509. PMCID: PMC8985041.

37. Hamano H, Kawa S, Horiuchi A, et al. 2001; High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 344:732–738. DOI: 10.1056/NEJM200103083441005. PMID: 11236777.

38. Macinga P, Bajer L, Del Chiaro M, et al. 2021; Pancreatic cancer in patients with autoimmune pancreatitis: A scoping review. Pancreatology. 21:928–937. DOI: 10.1016/j.pan.2021.03.007. PMID: 33775564.

39. Huang J, Lok V, Ngai CH, et al. 2021; Worldwide burden of, risk factors for, and trends in pancreatic cancer. Gastroenterology. 160:744–754. DOI: 10.1053/j.gastro.2020.10.007. PMID: 33058868.

40. Ben-Aharon I, van Laarhoven HWM, Fontana E, Obermannova R, Nilsson M, Lordick F. 2023; Early-onset cancer in the gastrointestinal tract is on the rise-evidence and implications. Cancer Discov. 13:538–551. DOI: 10.1158/2159-8290.CD-22-1038. PMID: 36757194.

41. Mauri G, Patelli G, Sartore-Bianchi A, et al. 2024; Early-onset cancers: Biological bases and clinical implications. Cell Rep Med. 5:101737. DOI: 10.1016/j.xcrm.2024.101737. PMID: 39260369. PMCID: PMC11525030.

42. Löhr JM, Pantel K. 2023; Five plus three for the pancreas. Clin Cancer Res. 29:1387–1389. DOI: 10.1158/1078-0432.CCR-22-3977. PMID: 36719761.

43. Schuurmans M, Alves N, Vendittelli P, Huisman H, Hermans J. PANCAIM Consortium. 2023; Artificial intelligence in pancreatic ductal adenocarcinoma imaging: A commentary on potential future applications. Gastroenterology. 165:309–316. DOI: 10.1053/j.gastro.2023.04.003. PMID: 37054755.

44. Liu J, Wang Y, Yu Y. 2020; Meta-analysis reveals an association between acute pancreatitis and the risk of pancreatic cancer. World J Clin Cases. 8:4416–4430. DOI: 10.12998/wjcc.v8.i19.4416. PMID: 33083401. PMCID: PMC7559689.

45. Maisonneuve P, Lowenfels A. Pancreatic cancer risks in chronic pancreatitis. In: Beger HG, Warshaw AL, Hruban RH, et al., eds. The Pancreas: An Integrated Textbook of Basic Science, Medicine, and Surgery. New York NY: John Wiley Sons Ltd., 2023: 480-485.

46. Gandhi S, de la Fuente J, Murad MH, Majumder S. 2022; Chronic pancreatitis is a risk factor for pancreatic cancer, and incidence increases with duration of disease: A systematic review and meta-analysis. Clin Transl Gastroenterol. 13:e00463. DOI: 10.14309/ctg.0000000000000463. PMID: 35142721. PMCID: PMC8963838.